Berberine has built a strong reputation in the metabolic health space. It is commonly used for blood sugar support, insulin sensitivity, and weight management.
But there is a problem most consumers only discover after trying it.
Standard berberine is poorly absorbed.
A significant portion of what you take may never meaningfully enter your bloodstream, which is why higher doses are typically required [1]. That limitation has led to the emergence of newer compounds like dihydroberberine (DHB), often marketed as a more advanced version of berberine.
Katalyx positions its DHB capsules as a next-generation solution. The promise is straightforward: better absorption, lower doses, and fewer digestive side effects.
This review takes a strict, evidence-based look at those claims, breaks down the label, and assesses whether Katalyx DHB is genuinely different or simply a more expensive variation of a familiar supplement.
We write about why this kind of label-level scrutiny matters so much. You can read our full philosophy here: Why We Write Independent Reviews of Diabetes Supplements — and Why We’re So Frustrated.
What Is Dihydroberberine (DHB)?
Dihydroberberine is a reduced form of berberine that behaves differently in the digestive system.
Instead of relying on berberine to pass through the gut wall, DHB appears to be:
- More readily absorbed in the intestine
- Converted back into active berberine once inside the body [2]
This distinction matters because it may allow the body to access berberine more efficiently.
The Absorption Problem — And Where DHB Fits
Standard berberine is known to have relatively low oral bioavailability, largely due to poor intestinal absorption and active efflux by transport proteins such as P-glycoprotein [1][3].
Dihydroberberine takes a different approach.
It is designed to be more efficiently absorbed, then converted into active berberine within the body. Early research suggests this may allow similar circulating levels to be achieved at lower doses [2][4].
However:
- Evidence is still emerging
- Large-scale human trials are limited
- Improved absorption does not always guarantee superior outcomes
Evidence Summary Panel
Compound: Dihydroberberine (DHB)
Category: Modified berberine derivative
What the evidence suggests:
- May have higher bioavailability than standard berberine [2][4]
- May achieve similar plasma levels at lower doses [4]
- May reduce gastrointestinal side effects in some users
What is still unclear:
- Long-term clinical outcomes in large populations
- Whether improved absorption leads to superior metabolic results
- Optimal dosing across different health conditions
Overall evidence strength: Moderate but emerging
Want to See How This Actually Affects Your Blood Sugar?
One of the biggest gaps with supplements like DHB is you can’t feel what’s happening in real time.
This is where continuous glucose monitoring becomes valuable.
If you are experimenting with berberine or DHB, using a CGM allows you to:
- See how your blood sugar responds to meals
- Track whether supplements are reducing spikes
- Identify which foods trigger the biggest glucose swings
Read our full guide: How This CGM Dropped My A1C from 9 to 6 in Just 6 Months
This is especially useful if your goal is to “eat your meter” and personalise your approach, rather than relying purely on supplement claims.
Claimed Benefits — Realistic Breakdown
Higher Absorption
This is the most credible claim.
Studies suggest DHB may be absorbed more efficiently than berberine hydrochloride, potentially resulting in higher plasma exposure at lower doses [2][4].
Verdict: Supported, but still early-stage evidence
Appetite and Sugar Cravings
Berberine has been shown to improve glycaemic control and insulin sensitivity, which may indirectly influence hunger and cravings [5].
However, direct evidence for DHB specifically affecting appetite is limited.
Verdict: Possible, but not well established
Metabolism Support
Berberine activates AMP-activated protein kinase (AMPK), a key regulator of energy metabolism [6].
This may contribute to modest improvements in metabolic efficiency, but it is not a strong or immediate “metabolism boost”.
Verdict: Mechanistically supported, but overstated in marketing
Blood Sugar and Insulin Support
This is where berberine has the strongest evidence base.
Clinical studies have shown berberine can:
- Reduce fasting blood glucose
- Improve insulin sensitivity
- Lower HbA1c in some populations [5][7]
DHB may enhance delivery, but equivalent large-scale human data is still lacking.
Verdict: Supported for berberine, emerging for DHB
How to Choose a High-Quality Berberine (or DHB)
Not all products in this category are created equal.
Before buying, it’s worth understanding:
- The difference between berberine HCl vs DHB
- Effective dosing ranges
- Red flags in supplement marketing
- What “third-party tested” actually means
Read the full breakdown here: How to Choose a High-Quality Berberine Supplement
This guide will help you avoid underdosed or misleading products.
Full Label Analysis — What Matters Most
Active Ingredient
- Dihydroberberine (DHB)
Effective ranges based on current research:
- Approximately 100–300 mg daily [4]
Underdosing may limit effectiveness.
Excipients and Capsule Quality
Look for:
- Minimal fillers
- Transparent ingredient listing
- High-quality capsule materials
Manufacturing and Testing
Credible products should include:
- Third-party testing
- Batch traceability
- Clear manufacturing standards
DHB vs Standard Berberine
| Feature | Standard Berberine | Dihydroberberine |
|---|---|---|
| Absorption | Low [1] | Higher (early data) [2] |
| Typical Dose | 1000–1500 mg/day | 100–300 mg/day |
| GI Side Effects | Common [3] | Potentially lower |
| Research Depth | Extensive | Limited |
| Cost | Lower | Higher |
Regulatory Context (Australia)
In Australia, supplements like DHB are regulated under the Therapeutic Goods Act 1989.
The Australian Competition and Consumer Commission also enforces rules against misleading health claims.
This means:
- Supplements cannot claim to treat or cure disease
- Evidence must support all claims
- Absolute statements (e.g. “no side effects”) are not permitted
Final Verdict — Is Katalyx DHB Worth It?
Katalyx DHB represents a technically interesting evolution of berberine rather than a complete breakthrough.
Strengths
- Improved absorption potential
- Lower dosing requirements
- Possible reduction in GI discomfort
Limitations
- Limited human clinical data
- Higher cost
- Benefits remain incremental
Bottom Line
Dihydroberberine is promising, but still developing.
Katalyx DHB may be worth considering if:
- You struggled with berberine side effects
- You want a lower-dose alternative
- You understand the evidence is still emerging
Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided is based on publicly available research and independent analysis at the time of writing.
Katalyx Dihydroberberine (DHB) and similar supplements are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary depending on factors such as diet, lifestyle, existing health conditions, and medication use.
If you have a medical condition, including insulin resistance, prediabetes, or type 2 diabetes, or are taking prescription medications, you should consult a qualified healthcare professional before starting any supplement, including berberine or dihydroberberine.
Do not disregard professional medical advice or delay seeking it because of something you have read in this article.
References
- Liu YT, Hao HP, Xie HG, et al. “Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels.” Drug Metabolism and Disposition. 2010.
- Turner N, Li JY, Gosby A, et al. “Berberine and its derivatives: metabolic effects.” Metabolism.
- Feng R, Shou JW, Zhao ZX, et al. “Transforming berberine into its intestine-absorbable form improves metabolic disorders.” Scientific Reports. 2015.
- Shou JW, Zhang X, Zheng Y, et al. “Enhanced oral bioavailability of dihydroberberine compared to berberine.” Journal of Natural Products.
- Yin J, Xing H, Ye J. “Efficacy of berberine in type 2 diabetes.” Metabolism. 2008.
- Zhang Y, Li X, Zou D, et al. “Berberine activates AMPK.” Journal of Clinical Endocrinology & Metabolism.
- Lan J, Zhao Y, Dong F, et al. “Meta-analysis of berberine in type 2 diabetes.” Journal of Ethnopharmacology.
